Myeloperoxidase News and Research

RSS
Myeloperoxidase (MPO) is a peroxidase enzyme most abundantly present in neutrophil granulocytes (a subtype of white blood cells). It is a lysosomal protein stored in azurophilic granules of the neutrophil. MPO has a heme pigment, which causes its green color in secretions rich in neutrophils, such as pus and some forms of mucus.
Consuming green tea with dietary iron may lessen health benefits of green tea

Consuming green tea with dietary iron may lessen health benefits of green tea

Statins benefit patients undergoing major lung resection, lower major complications

Statins benefit patients undergoing major lung resection, lower major complications

Study shows that plant-based vegan diet may lower heart disease risk in obese children

Study shows that plant-based vegan diet may lower heart disease risk in obese children

Boston Heart Diagnostics announces commercial launch of FDA-cleared MPO test

Boston Heart Diagnostics announces commercial launch of FDA-cleared MPO test

Good mood reduces stress-induced effects in musicians

Good mood reduces stress-induced effects in musicians

Airway alterations present even in young smokers without COPD

Airway alterations present even in young smokers without COPD

New procedure to treat acid reflux can prevent chronic rejection in lung transplant patients

New procedure to treat acid reflux can prevent chronic rejection in lung transplant patients

Research report helps explain how macrophages accumulate triglycerides

Research report helps explain how macrophages accumulate triglycerides

Research identifies new pathway to target with anti-inflammatory drugs

Research identifies new pathway to target with anti-inflammatory drugs

ANCA-associated vasculitis not a single clinical entity

ANCA-associated vasculitis not a single clinical entity

CHL completes $18.4-million Series B financing round

CHL completes $18.4-million Series B financing round

Highly favorable final results from ERGOFLEX initial clinical study for joint pain relief

Highly favorable final results from ERGOFLEX initial clinical study for joint pain relief

OXIS International files patent application to strengthen Ergothioneine intellectual property portfolio

OXIS International files patent application to strengthen Ergothioneine intellectual property portfolio

OXIS introduces ErgoFlex for relief of joint pain

OXIS introduces ErgoFlex for relief of joint pain

Ergothioneine international congress 2011 to be held at UCLA

Ergothioneine international congress 2011 to be held at UCLA

Study reveals two enzymes help immune cells deploy pathogen-killing traps

Study reveals two enzymes help immune cells deploy pathogen-killing traps

Estee Lauder subsidiary and OXIS resolve mitochondria patent dispute

Estee Lauder subsidiary and OXIS resolve mitochondria patent dispute

First World Congress on Ergothioneine to be held in Los Angeles, California in July 2011

First World Congress on Ergothioneine to be held in Los Angeles, California in July 2011

OXIS International to introduce new ergothioneine-based products for joint health and healthy aging

OXIS International to introduce new ergothioneine-based products for joint health and healthy aging

New data on Surfaxin LS presented at 2010 PAS Annual Meeting

New data on Surfaxin LS presented at 2010 PAS Annual Meeting